Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention

Stopped End of the COVID 19 epidemic in the region and decision to participate in a national study on the same subject (COVI-DOSE).

Conditions

• Sars-CoV2

Interventions

• DRUG: Lovenox 40 MG in 0.4 mL Prefilled Syringe
• DEVICE: Ultrasound of the lower limbs

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Collaborators

• [object Object]